Form 8-K - Current report:
SEC Accession No. 0001144204-12-035911
Filing Date
2012-06-22
Accepted
2012-06-22 08:50:48
Documents
3
Period of Report
2012-06-22
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v316709_8k.htm 8-K 15815
2 EXHIBIT 99.1 v316709_ex99-1.htm EX-99.1 8231
3 EXHIBIT 99.2 v316709_ex99-2.htm EX-99.2 13345
  Complete submission text file 0001144204-12-035911.txt   38763
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 12920938
SIC: 2836 Biological Products, (No Diagnostic Substances)